Figuring out how long it's taken the Multidisciplinary Association for Psychedelic Studies' (MAPS) application to reach the FDA’s desk all depends on when you start counting. The organization was ...
Please provide your email address to receive an email when new articles are posted on . ATA3219 is an allogeneic CAR T-cell therapy being investigated in the treatment of SLE with lupus nephritis. The ...
NRx together with Osmind, Inc. conducted an in-person meeting attended by leadership of the FDA Division of Psychiatry Products and leadership of the FDA Center for Drug Evaluation and Research (CDER) ...
Nearly 1,600 Pennsylvanians enrolled in the state’s HIV/AIDS assistance program have lost or will lose benefits due to program changes brought on by years of stagnant federal funding, according to the ...
GlobalData on MSN
FDA issues CRL to Aldeyra’s reproxalap drug application
During the review process, the FDA provided label drafts in December 2025 and March 2026.
Understanding the requirements behind the FDA’s New Drug Application process can save substantial time in the development of biopharmaceuticals and allow companies in the life sciences sector to ...
According to the US FDA (https://www.fda.gov/industry/medical-products-rare-diseases-and-conditions/designating-orphan-product-drugs-and-biological-products). “NV ...
Under a proposed pilot program, clinics and hospitals would pay full wholesale price, then request an after-purchase rebate.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results